GAS5 and systemic lupus erythematosus: Subsequently, a risk score based on GAS5 and linc0597 from validation set was further assessed in SLE patients and all controls, the AUC for the risk score was 0.853 (95% CI: 0.807-0.899; P < 0.001; sensitivity = 79.75%, specificity = 82.31%).